Cardioprotective effect of fluvastatin XL
Between June 2004 and April 2008 the Dutch DECREASE III Study observed patients treated with Fluvastatin. The results show that Fluvastatin XL therapy can be associated with improved postoperative cardiac outcome in high-risk patients undergoing elective vascular surgery.
















